Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Ruth Harman


Trial Manager - Oncology Clinical Trials Office (OCTO)

I joined the Oncology Clinical Trials Office (OCTO) as a Trial Manager in May 2019. Prior to this I was a Research Administrator for the HOME Study in the University’s Department of Psychiatry.

I am currently working on the following trials:

ARCADIAN trial – a phase I study to assess the safety of combining the drug atovaquone with concurrent chemoradiotherapy in locally advanced Non-Small Cell Lung Cancer.

CHARIOT – A phase I dose escalation safety study combining the ATR inhibitor M6620 with chemoradiotherapy in oesophageal cancer & other solid cancers using time to event continual reassessment method.

CYTOFLOC – Evaluation of a Non‐Endoscopic Immunocytological Device (Cytosponge™) for post chemo‐radiotherapy surveillance in patients with oesophageal cancer – a feasibility study.

Further information on these trials and other OCTO studies can be found here.